Do any of yall still have the urge to binge if you're on a GLP-1 like semaglutide or tirzepatide

Understanding How GLP-1 Medications Affect Binge Eating

As the founder of CFP Weight Loss and author of The CFP Method, I've worked with thousands of adults in their late 40s and early 50s who battle constant binge urges amid hormonal shifts, joint pain, and blood sugar instability. GLP-1 receptor agonists such as semaglutide (found in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) target the same gut-brain pathways that regulate hunger. They slow gastric emptying, increase satiety signals, and reduce the reward value of highly palatable foods. In clinical trials, participants reported up to 60-70% reduction in food cravings within the first 8-12 weeks.

However, these medications do not erase the urge to binge for everyone. About 20-30% of users in my programs still experience breakthrough binge impulses, especially during dose titration or high-stress periods. This is because emotional triggers, habitual patterns, and insulin resistance often remain even as physical hunger decreases.

What Real Beginners Experience on Semaglutide and Tirzepatide

Many of my clients with type 2 diabetes and hypertension note their constant “food noise” quiets dramatically by week 4 on 0.5 mg semaglutide or 2.5 mg tirzepatide. They no longer obsess over evening snacks or feel compelled to finish an entire bag of chips. Yet when life throws curveballs—work deadlines, family tension, or skipped meals—some still reach for comfort foods. Joint pain often limits movement, so the emotional component of binge eating stays strong if not addressed directly.

The key difference: on these GLP-1 drugs, a binge episode typically stops after far fewer calories. One client described eating only four cookies instead of the usual dozen because fullness signals kicked in sooner. This smaller “damage radius” makes it easier to get back on track without the crushing guilt that derails most diets.

Practical Strategies from The CFP Method to Eliminate Remaining Urges

My approach combines the biological power of GLP-1 therapy with simple behavioral tools that fit busy middle-income lives. First, stabilize blood glucose by pairing medication with 25-30 grams of protein at every meal; this further dampens cravings. Second, use a 5-minute “pause protocol” the moment an urge appears—drink 12 oz of water, walk slowly around the house (joint-friendly), then reassess. Third, schedule one weekly “controlled indulgence” of 150-200 calories of a favorite food so deprivation doesn’t fuel secret binges.

Track non-scale victories like reduced joint inflammation, steadier blood pressure readings (many drop 10-15 systolic points), and improved energy. These wins keep motivation high when insurance denies coverage and old diet failures loom large. Most clients lose 1-2 pounds per week sustainably without complex meal plans—just three consistent habits repeated daily.

Long-Term Success and When to Seek Extra Support

After 6-12 months on therapeutic doses (1.0-2.4 mg semaglutide or 10-15 mg tirzepatide), roughly 75% of my program participants report binge urges occur less than once per month. The remaining 25% benefit from adding short cognitive behavioral exercises from The CFP Method workbook. If urges persist despite medication, check for underlying issues like sleep apnea, low thyroid, or medication timing. Always work with your prescribing physician to adjust doses safely.

Remember, these drugs give you a powerful biological advantage, but lasting freedom from binge eating comes from rebuilding trust with your body—one small, repeatable step at a time. You don’t need another restrictive diet. You need a method that respects your hormones, your schedule, and your history of past failures.